View Older Stories View More Recent Stories
-
Hana Biosciences (HNAB) Announces $100M Preferred Private Placement
-
Arena Pharma (ARNA) Enters $35.5M Common Private Placement with Deerfield Mangement
-
Exelixis (EXEL) Announces $160M in New Financing Agreements
-
BioSante Pharma (BPAX) Closes 10.4M Common Registered Direct Offering; $18M in Gross Proceeds
-
BioSante Pharma (BPAX) to Raise $17.5M in Direct Offering of Common Stock and Warrants
-
Rockwell Medical (RMTI) Completes $22 Million Offering
-
Insulet (PODD) Amends Deerfield Credit Facility; Issues 2.855M Shares
-
Array BioPharma (ARRY) Enters into Equity Distribution Agreement To Sell Up To $25M
-
NeuroMetrix (NURO) Announces Commitments from Institutional Investors to Buy $18.68M in Common Shares
-
Arena Pharma (ARNA) Agrees to Receive $100M from Deerfield Management
-
Array BioPharma (ARRY) Receives Additional $40 Million Funding Commitment From Deerfield Management
-
VIVUS (VVUS) Announces Initiation of Open Label Safety Study for ED
-
ZymoGenetics (ZGEN) Reports Smaller-Than-Expected Q1 Loss
-
Insulet (PODD) Announces $60M Funding Commitment From Deerfield Management
-
NitroMed (NTMD) Announces Merger Agreement with Deerfield Management
-
NitroMed (NTMD) Agrees to be Acquired by Deerfield Management for $0.80/Share
-
Deerfield Management Increases Its Offer For NitroMed (NTMD)
-
NitroMed (NTMD) Confirms Receipt of Letter from Deerfield Management
-
Notable Mergers and Acquisitions of the Day 12/05: MER/BAC, NTMD, RSG/AW
-
NitroMed (NTMD) Receives Acquisition Offer From Deerfield Management
-
ISTA Pharmaceuticals (ISTA) Receives $65 Million Funding Commitment
-
ZymoGenetics (ZGEN) Receives $100M Funding Commitment From Deefield
-
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
-
Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials
